Cardinal Health Recalls Neomycin Sulfate Tablets Due to Storage Temperature Excursions
Cardinal Health Inc. is recalling 41 bottles of Neomycin Sulfate 500mg tablets distributed in Florida, Georgia, and South Carolina due to intermittent temperature excursions during storage.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a Moderate severity score (2) in the absence of reported injuries or more severe hazards like structural defects or high-risk pathogens.
Plain-English summary
Cardinal Health Inc. is recalling 41 bottles of Neomycin Sulfate Tablets, USP, 500mg, 100-count. The product is distributed by Teva Pharmaceuticals USA, Inc. and is identified by NDC 0093-1177-01. The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations involving intermittent exposure to temperature excursions during storage.
The affected product was distributed in Florida, Georgia, and South Carolina. The specific code for the recalled product is 3006910. This is a Class II recall, which indicates that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Consumers and healthcare providers should check their inventory for this specific product and code. If found, the product should be quarantined and not used. For further information, please contact the recalling firm or the FDA.
The recalled product
- Product
- NEOMYCIN SULFATE (NEOMYCIN SULFATE)
- Brand
- NEOMYCIN SULFATE
- Manufacturer
- Cardinal Health Inc.
- Category
- Drug — Antibiotic
- Hazard
- Affected units
- 41
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- 3006910
UPCs (1)
- 0300931177018
Distribution
Part of a larger recall action
This product is one of 198 recalled by Cardinal Health Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 198 products in this recall →Related recalls
Same brand · NEOMYCIN SULFATE
- HighPrescription Antibiotic Tablets Recalled for Foreign Matter in Active Ingredient
FDA (Drugs) · 2022-09-07
Same manufacturer · Cardinal Health Inc.
See all →- HighEnoxaparin syringe bags recalled after being labeled with the wrong strength
FDA (Drugs) · 2025-09-03
- ModerateXolair auto-injectors exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateRecombinate antihemophilic factor vials exposed to temperatures outside labeled storage
FDA (Drugs) · 2025-08-13
- ModerateXolair 75 mg syringes exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateWegovy injection recalled due to temperature exposure during shipping
FDA (Drugs) · 2025-05-07
Same hazard · temperature excursion
See all →- ModerateCyclophosphamide injection vials recalled after a transportation temperature excursion
FDA (Drugs) · 2025-09-24
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30